BRP Inc. - DOO.TO

DOO.TO Returns vs S&P 500 ⓘ

ticker	1 day return %	1 week return %	1 month return %	3 months return %	6 months return %	1 year return %	3 years return %	5 years return %	10 years return %	maximum return %
DOO.TO	1.0	1.1	-14.6	-28.4	-27.3	-34.8	-39.2	9.3	162.2	182.2
S&P 500	-1.3	-1.9	0.1	5.7	10.7	29.1	24.8	88.0	186.1	33142.5

Compare DOO.TO with other assets →

Returns Charts ⓘ

Interactive Price Chart

Our interactive price chart includes various drawing tools to help you analyze the product more effectively. Below is a quick guide on how to use these tools: Full Guideline

Real-time Full Quote

Attribute	Value
symbol	DOO.TO
name	BRP Inc.
price	67.75
changes percentage	1.044
change	0.7
day low	66.79
day high	68.22
year high	104.3
year low	66.17
market cap	4932645863
price avg 50	77.0346
price avg 200	87.7606
exchange	TSX
volume	155986
avg volume	244336
open	66.87
previous close	67.05
eps	3.3
pe	20.53
earnings announcement	2024-12-06T11:00:00.000+0000
shares outstanding	72806581
timestamp	2024-11-15 21:00:00

Financial Statements ⓘ

We derive the score of a company's financial statements by evaluating the weighted average sentiment across key within the statements. The cumulative score, normalized to a sum of 1, serves as a metric for assessing the company's performance during the specified period. A higher score indicates stronger performance. However, it's crucial to note that while this score provides valuable insights, it is just one of many factors to consider when making informed investment decisions. A holistic evaluation, considering various aspects of the company's financial health and market conditions, is essential for a well-rounded investment strategy.

Overall Annual Financial Health: 53.3%

Overall Quarterly Financial Health: 48.3%

Income Statements ⓘ

• Annual Income Statement

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0000000000
revenue	10367000000	10033400000	3.32
gross profit	2601300000	2499400000	4.08
gross profit ratio	0.25	0.25	0.73
research and development expenses	482100000	367700000	31.11
operating expenses	1342300000	1138200000	17.93
interest income	16600000	6000000	176.67
interest expense	181100000	114200000	58.58
ebitda	1508000000	1541800000	-2.19
ebitdaratio	0.15	0.17	-12.97
operating income	1157000000	1367100000	-15.37
operating income ratio	0.11	0.14	-18.09
net income	743400000	863900000	-13.95
net income ratio	0.07	0.09	-16.72
eps	9.63	10.88	-11.49

Overall Score of Annual Income Statement

0.38 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Revenue Growth: revenue increased to 10,367 million in 2023 from 10,033 million in 2022 representing a change of 3.32%. This indicates a sales growth, which is a positive sign for the company.

  Gross Profit: Gross Profit increased to 2,601 million in 2023 from 2,499 million in 2022 representing a change of 4.08%. This indicates a sales profitability growth, which is a positive sign for the company.

  Research and Development (R&D) Expenses: R&D Expenses increased to 482 million in 2023 from 368 million in 2022 representing a change of 31.11%. This shows that the company continues to invest in innovation and product development, which is crucial for long-term growth.

• 📉 Negative Indicators

  Operating Expenses: Operating Expenses increased to 1,342 million in 2023 from 1,138 million in 2022 representing a change of 17.93%. The increase in operating expenses can be attributed to various factors such as marketing, administrative costs, and investments in infrastructure. It's important to monitor if these expenses are growing at a sustainable rate compared to revenue.

  EBITDA: EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) decreased to 1,508 million in 2023 from 1,542 million in 2022 representing a change of -2.19%. The decrease in EBITDA indicates declined operational efficiency and profitability.

  Operating Income: Operating income decreased to 1,157 million in 2023 from 1,367 million in 2022 representing a change of -15.37%. The decrease in operating income indicates worse operational performance and decreased profitability.

  Net Income: Net income decreased to 743 million in 2023 from 864 million in 2022 representing a change of -13.95%. The decrease in net income shows worsen profitability and indicates that the company is generating less profit for each dollar of revenue.

  Earnings per Share (EPS): EPS increased to 9.63 in 2023 from 9.63 in 2022 representing a change of -11.49%. This indicates that the company's earnings are decreasing and it is becoming less profitable on a per-share basis.

• Quarterly Income Statement

Note: The years below are fiscal years in accounting.

	2024Q2	2024Q1	Q/Q change %
0000000000
revenue	1841900000	2031700000	-9.34
gross profit	376500000	480000000	-21.56
gross profit ratio	0.2	0.24	-13.48
research and development expenses	84400000	115300000	-26.80
operating expenses	282000000	338800000	-16.77
interest income	4000000	1800000	122.22
interest expense	48600000	46500000	4.52
ebitda	172200000	157900000	9.06
ebitdaratio	0.09	0.12	-22.44
operating income	74400000	141200000	-47.31
operating income ratio	0.04	0.07	-41.88
net income	6600000	-7600000	186.84
net income ratio	0.0	-0.0	195.79
eps	0.09	-0.1	189.50

Overall Score of Quarterly Income Statement

0.75 out of 1

Detailed Analysis

• 📉 Negative Indicators

  Revenue Growth: revenue decreased to 1,842 million in 2024Q2 from 2,032 million in 2024Q1 representing a change of -9.34%. This indicates a sales shrinking, which is a negative sign for the company.

  Gross Profit: Gross Profit decreased to 376 million in 2024Q2 from 480 million in 2024Q1 representing a change of -21.56%. This indicates a sales profitability decline, which is a negative sign for the company.

• 📈 Positive Indicators

  Research and Development (R&D) Expenses: R&D Expenses increased to 84 million in 2024Q2 from 115 million in 2024Q1 representing a change of -26.8%. This shows that the company continues to invest in innovation and product development, which is crucial for long-term growth.

  Operating Expenses: Operating Expenses decreased to 282 million in 2024Q2 from 339 million in 2024Q1 representing a change of -16.77%. The decrease in operating expenses can be attributed to various factors such as improved profitability, cost optimization and financial stability, lower operating expenses can be positive indicators.

  EBITDA: EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) increased to 172 million in 2024Q2 from 158 million in 2024Q1 representing a change of 9.06%. The increase in EBITDA indicates improved operational efficiency and profitability.

  Operating Income: Operating income increased to 74 million in 2024Q2 from 141 million in 2024Q1 representing a change of -47.31%. The increase in operating income indicates better operational performance and increased profitability.

  Net Income: Net income increased to 7 million in 2024Q2 from -8 million in 2024Q1 representing a change of 186.84%. The increase in net income shows improved profitability and indicates that the company is generating more profit for each dollar of revenue.

  Earnings per Share (EPS): EPS increased to 0.09 in 2024Q2 from 0.09 in 2024Q1 representing a change of 189.5%. This indicates that the company's earnings are increasing and it is becoming more profitable on a per-share basis.

Balance Sheets ⓘ

• Annual Balance Sheet

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0000000000
total assets	6775500000	6464600000	4.81
total liabilities	5961600000	5924500000	0.63
total equity	813900000	540100000	50.69
cash and cash equivalents	491800000	202300000	143.10
short term investments	106600000	122600000	-13.05
long term investments	49600000	69300000	-28.43
total current assets	3528800000	3380600000	4.38
total non current assets	3246700000	3084000000	5.28
total current liabilities	2505100000	2483300000	0.88
total non current liabilities	3456500000	3441200000	0.44
common stock	248500000	255800000	-2.85
retained earnings	443100000	175500000	152.48
total debt	2951400000	3016100000	-2.15

Overall Score of Annual Balance Sheet

0.6 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Total Assets: Total Assets increased to 6,776 million in 2023 from 6,465 million in 2022 representing a change of 4.81%. Suggesting a growth in asset holdings.

  Total Equity: Total Equity increased to 814 million in 2023 from 540 million in 2022 representing a change of 50.69%. This indicates an increase in shareholders' equity.

  Cash And Cash Equivalents: Cash And Cash Equivalents increased to 492 million in 2023 from 202 million in 2022 representing a change of 143.1%. This indicates an increase in available liquid assets.

  Total Current Assets: Total Current Assets increased to 3,529 million in 2023 from 3,381 million in 2022 representing a change of 4.38%. This indicates a better liquidity position.

  Retained Earnings: Retained Earnings increased to 443 million in 2023 from 176 million in 2022 representing a change of 152.48%. This indicates an accumulated profits.

  Total Debt: Total Debt decreased to 2,951 million in 2023 from 3,016 million in 2022 representing a change of -2.15%. This indicates a reduction in overall debt burden.

• 📉 Negative Indicators

  Total Liabilities: Total Liabilities increased to 5,962 million in 2023 from 5,924 million in 2022 representing a change of 0.63%. This indicates an increase in overall liabilities.

  Short Term Investments: Short Term Investments decreased to 107 million in 2023 from 123 million in 2022 representing a change of -13.05%. This indicates a decrease in short-term investment holdings.

  Total Current Liabilities: Total Current Liabilities increased to 2,505 million in 2023 from 2,483 million in 2022 representing a change of 0.88%. This indicates a higher short-term debt burden.

  Common Stock: Common Stock decreased to 248 in 2023 from 256 in 2022 representing a change of -2.85%. This indicates a decrease in ownership interest.

• Quarterly Balance Sheet

Note: The years below are fiscal years in accounting.

	2024Q2	2024Q1	Q/Q change %
0000000000
total assets	6378400000	6642900000	-3.98
total liabilities	5824300000	5988600000	-2.74
total equity	554100000	654300000	-15.31
cash and cash equivalents	165400000	417400000	-60.37
short term investments	117200000	117300000	-0.09
long term investments	28400000	39300000	-27.74
total current assets	3076500000	3353100000	-8.25
total non current assets	3301899999	3289799999	0.37
total current liabilities	2333900000	2492500000	-6.36
total non current liabilities	3490400000	3496100000	-0.16
common stock	249800000	256300000	-2.54
retained earnings	210700000	381200000	-44.73
total debt	3024000000	3018600000	0.18

Overall Score of Quarterly Balance Sheet

0.2 out of 1

Detailed Analysis

• 📉 Negative Indicators

  Total Assets: Total Assets decreased to 6,378 million in 2024Q2 from 6,643 million in 2024Q1 representing a change of -3.98%. Suggesting a decrease in asset holdings.

  Total Equity: Total Equity decreased to 554 million in 2024Q2 from 654 million in 2024Q1 representing a change of -15.31%. This indicates a decrease in shareholders' equity.

  Cash And Cash Equivalents: Cash And Cash Equivalents decreased to 165 million in 2024Q2 from 417 million in 2024Q1 representing a change of -60.37%. This indicates a decrease in available liquid assets.

  Short Term Investments: Short Term Investments decreased to 117 million in 2024Q2 from 117 million in 2024Q1 representing a change of -0.09%. This indicates a decrease in short-term investment holdings.

  Total Current Assets: Total Current Assets decreased to 3,076 million in 2024Q2 from 3,353 million in 2024Q1 representing a change of -8.25%. This indicates a worsen liquidity position.

  Common Stock: Common Stock decreased to 250 in 2024Q2 from 256 in 2024Q1 representing a change of -2.54%. This indicates a decrease in ownership interest.

  Retained Earnings: Retained Earnings decreased to 211 million in 2024Q2 from 381 million in 2024Q1 representing a change of -44.73%. This indicates an accumulated losses.

  Total Debt: Total Debt increased to 3,024 million in 2024Q2 from 3,019 million in 2024Q1 representing a change of 0.18%. This indicates an increase in overall debt burden.

• 📈 Positive Indicators

  Total Liabilities: Total Liabilities decreased to 5,824 million in 2024Q2 from 5,989 million in 2024Q1 representing a change of -2.74%. This indicates a decrease in overall liabilities.

  Total Current Liabilities: Total Current Liabilities decreased to 2,334 million in 2024Q2 from 2,492 million in 2024Q1 representing a change of -6.36%. This indicates a lower short-term debt burden.

Cashflow Statements ⓘ

• Annual Cashflow Statement

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0000000000
net change in cash	289500000	-63500000	555.91
operating cash flow	1490500000	649500000	129.48
free cash flow	904700000	-9900000	9238.38
capital expenditure	-585800000	-659400000	11.16
depreciation and amortization	391700000	310400000	26.19
deferred income tax	-35000000	300500000	-111.65
stock based compensation	0	19500000	-100.00
accounts payables	-96100000	-248600000	61.34
inventory	122600000	-513900000	123.86
acquisitions net	0	-208200000	100.00
investments in property plant and equipment	-585800000	-659400000	11.16
net cash used for investing activites	-574900000	-853400000	32.63
debt repayment	-132500000	662600000	-120.00
common stock issued	18200000	10800000	68.52
common stock repurchased	-446200000	-305500000	-46.06
dividends paid	-55600000	-50800000	-9.45
net cash used provided by financing activities	-629200000	190300000	-430.64
cash at end of period	491800000	202300000	143.10
accounts receivables	3700000	-166300000	102.22
cash at beginning of period	202300000	265800000	-23.89

Overall Score of Annual Cashflow Statement

0.62 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Net Change in Cash: Net Change in Cash increased to 290 million in 2023 from -64 million in 2022 representing a change of 555.91%. Indicating an increased ability to generate cash from the company's operations or its cash flow position.

  Operating Cash Flow: Operating Cash Flow increased to 1,490 million in 2023 from 650 million in 2022 representing a change of 129.48%. This indicates that the company generated more cash from its core business operations.

  Free Cash Flow: Free Cash Flow increased to 905 million in 2023 from -10 million in 2022 representing a change of 9238.38%. This indicates an increase in cash generated after accounting for capital expenditures.

  Stock-Based Compensation: Stock-Based Compensation decreased to 0 million in 2023 from 20 million in 2022 representing a change of -100.0%. This indicates decreased expenses, which is generally considered a positive sign from a financial perspective.

  Accounts Payables: The absolute value of Accounts Payables decreased to 96 million in 2023 from 249 million in 2022 representing a change of 61.34%. This indicates that the company has reduced its outstanding obligations to its suppliers.

• 📉 Negative Indicators

  Capital Expenditure: Capital Expenditure increased to -586 million in 2023 from -659 million in 2022 representing a change of 11.16%. This indicates an increase in the cash outflow required for acquiring or improving long-term assets.

  Accounts Receivables: Accounts Receivables increased to 4 in 2023 from -166 million in 2022 representing a change of 102.22%. This suggests that the company is less capable of collecting payments from its customers.

  Dividends Paid: Dividends Paid decreased to -56 million in 2023 from -51 million in 2022 representing a change of -9.45%. This indicates a weaker financial position, less confidence in future prospects, and a reluctance to return value to shareholders.

• Quarterly Cashflow Statement

Note: The years below are fiscal years in accounting.

	2024Q2	2024Q1	Q/Q change %
0000000000
operating cash flow	66700000	97700000	-31.73
free cash flow	-38900000	22500000	-272.89
capital expenditure	-105600000	-75200000	-40.43
depreciation and amortization	107000000	103700000	3.18
deferred income tax	17800000	-48100000	137.01
stock based compensation	0	0	NaN
accounts receivables	111800000	156200000	-28.43
accounts payables	-57500000	-178600000	67.81
inventory	-10900000	-17600000	38.07
acquisitions net	0	0	NaN
investments in property plant and equipment	-105600000	-75200000	-40.43
net cash used for investing activites	-106600000	-74100000	-43.86
debt repayment	-33300000	-19300000	-72.54
common stock issued	4800000	8500000	-43.53
common stock repurchased	-167800000	-47300000	-254.76
dividends paid	-15300000	-15800000	3.16
net cash used provided by financing activities	-216200000	-74000000	-192.16
net change in cash	-252000000	-74400000	-238.71
cash at end of period	165400000	417400000	-60.37
cash at beginning of period	417400000	491800000	-15.13

Overall Score of Quarterly Cashflow Statement

0.5 out of 1

Detailed Analysis

• 📉 Negative Indicators

  Net Change in Cash: Net Change in Cash decreased to -252 million in 2024Q2 from -74 million in 2024Q1 representing a change of -238.71%. Indicating a declined ability to generate cash from the company's operations or its cash flow position.

  Operating Cash Flow: Operating Cash Flow decreased to 67 million in 2024Q2 from 98 million in 2024Q1 representing a change of -31.73%. This indicates that the company generated less cash from its core business operations.

  Free Cash Flow: Free Cash Flow decreased to -39 million in 2024Q2 from 22 million in 2024Q1 representing a change of -272.89%. This indicates a decrease in cash generated after accounting for capital expenditures.

  Deferred Income Tax: Deferred Income Tax increased to 18 million in 2024Q2 from -48 million in 2024Q1 representing a change of 137.01%. This indicates that the company's tax liability for future periods has increased.

• 📈 Positive Indicators

  Capital Expenditure: Capital Expenditure decreased to -106 million in 2024Q2 from -75 million in 2024Q1 representing a change of -40.43%. This indicates a possible improved efficiency or a shift in the company's strategic priorities.

  Accounts Payables: The absolute value of Accounts Payables decreased to 58 million in 2024Q2 from 179 million in 2024Q1 representing a change of 67.81%. This indicates that the company has reduced its outstanding obligations to its suppliers.

  Accounts Receivables: Accounts Receivables decreased to 112 million in 2024Q2 from 156 million in 2024Q1 representing a change of -28.43%. This suggests that the company has been able to collect payments from its customers more efficiently and timely.

  Dividends Paid: Dividends Paid increased to -15 million in 2024Q2 from -16 million in 2024Q1 representing a change of 3.16%. This indicates a stronger financial position, more confidence in future prospects, and a better commitment to returning value to shareholders.

Earnings Transcripts ⓘ

We save you time by utilizing Generative AI to summarize earnings transcripts. Our summaries provide a clear insight into the company's current performance, future outlook, and overall sentiment expressed during the call. Click on below links to explore more.

Note: The years mentioned below are fiscal years in accounting.

Q2 2025 Earnings call transcript
Q1 2025 Earnings call transcript
Q4 2024 Earnings call transcript
Q3 2024 Earnings call transcript
Q2 2024 Earnings call transcript
Q1 2024 Earnings call transcript
Q4 2023 Earnings call transcript
Q3 2023 Earnings call transcript

Earnings Per Share (EPS) ⓘ

Analyst Stock Recommendations ⓘ

Discover detailed analyst recommendations for stocks, including categories such as Buy, Hold, Sell, Strong Buy, and Strong Sell. These insights are based on thorough analysis of financial and market factors. The consensus is calculated by assigning a numerical score to each recommendation. These scores are then weighted and averaged over a specified period to provide a comprehensive view of the stock's outlook, with the final score determining the overall consensus.

Financial Ratios ⓘ

• Annual Financial Ratios

	2024-01-31	2023-01-31	Y/Y change %
FY
calendar year	2023	2022	NaN
revenue per share	134.35	126.39	6.29
net income per share	9.63	10.88	-11.48
operating cash flow per share	19.32	8.18	136.07
free cash flow per share	11.72	-0.12	9500.75
cash per share	7.75	4.09	89.47
book value per share	10.55	6.8	55.02
tangible book value per share	1.93	-2.53	176.08
shareholders equity per share	10.48	6.74	55.57
interest debt per share	38.15	36.95	3.25
market cap	6546806284.2	8813784348.24	-25.72
enterprise value	9006406284.2	11627584348.24	-22.54
pe ratio	8.81	10.2	-13.68
price to sales ratio	0.63	0.88	-28.11
pocfratio	4.39	13.57	-67.63
pfcf ratio	7.24	-890.28	100.81
pb ratio	8.09	16.48	-50.88
ptb ratio	8.09	16.48	-50.88
ev to sales	0.87	1.16	-25.04
enterprise value over ebitda	5.97	7.54	-20.81
ev to operating cash flow	6.04	17.9	-66.25
ev to free cash flow	9.96	-1174.5	100.85
earnings yield	0.11	0.1	15.85
free cash flow yield	0.14	-0.0	12402.75
debt to equity	3.42	5.27	-35.19
debt to assets	0.41	0.44	-6.49
net debt to ebitda	1.63	1.83	-10.63
current ratio	1.41	1.36	3.48
interest coverage	6.39	11.97	-46.63
income quality	2.0	0.75	167.15
dividend yield	0.01	0.01	47.35
payout ratio	0.07	0.06	27.19
sales general and administrative to revenue	0.04	0.03	7.88
research and ddevelopement to revenue	0.05	0.04	26.89
intangibles to total assets	0.1	0.11	-14.40
capex to operating cash flow	0.39	1.02	-61.29
capex to revenue	0.06	0.07	-14.02
capex to depreciation	1.5	2.12	-29.60
stock based compensation to revenue	0	0.0	-100.00
graham number	47.67	40.62	17.35
roic	0.25	0.3	-16.46
return on tangible assets	0.12	0.15	-19.40
graham net net	-48.56	-49.51	1.91
working capital	1023700000	897300000	14.09
tangible asset value	148800000	-201200000	173.96
net current asset value	-2432800000	-2543900000	4.37
invested capital	3862800000	3629300000	6.43
average receivables	708000000	598100000	18.37
average payables	985250000	954500000	3.22
average inventory	2222850000	1990700000	11.66
days sales outstanding	25.25	25.42	-0.70
days payables outstanding	48.26	45.72	5.56
days of inventory on hand	101.32	110.95	-8.68
receivables turnover	14.46	14.36	0.70
payables turnover	7.56	7.98	-5.27
inventory turnover	3.6	3.29	9.51
roe	0.92	1.62	-43.10
capex per share	7.59	8.31	-8.61

• Neutral

  ROE: Return on Equity (ROE) decreased to 0.92 on 2024-01-31 from 1.62 on 2023-01-31, representing a change of -43.10%. However, ROE is >= 15%, suggesting that the company has been generating high returns for its shareholders still.

• Negative

  PE Ratio: Price-to-Earnings (P/E) Ratio decreased to 8.81 on 2024-01-31 from 10.20 on 2023-01-31, representing a change of -13.68%. Indicating a decrease in the relative valuation of the company's stock.

  Debt-to-Equity Ratio: Debt-to-Equity Ratio decreased to 3.42 on 2024-01-31 from 5.27 on 2023-01-31, representing a change of -35.19%. The debt-to-equity ratio has been decreasing, indicating that the company has been relying less on debt financing. However, a ratio of 2.0 or higher is usually considered risky.

• Positive

  Current Ratio: Current Ratio increased to 1.41 on 2024-01-31 from 1.36 on 2023-01-31, representing a change of 3.48%. The current ratio has been increasing, suggesting an increase in the company's short-term liquidity. Also, it's above 1, indicating the ability to cover short-term obligations.

• Quarterly Financial Ratios

	2024-07-31 Q2	2024-04-30 Q1	Q/Q change %
DOO.TO
calendar year	2024	2024	NaN
revenue per share	24.97	27.13	-7.94
net income per share	0.09	-0.1	188.19
operating cash flow per share	0.9	1.3	-30.67
free cash flow per share	-0.53	0.3	-275.57
cash per share	3.83	7.14	-46.33
book value per share	7.51	8.74	-14.00
tangible book value per share	-1.48	-0.15	-888.28
shareholders equity per share	7.43	8.66	-14.28
interest debt per share	38.96	38.4	1.46
market cap	7377818881.86	6937044053.72	6.35
enterprise value	10236418881.86	9538244053.72	7.32
pe ratio	279.46	-228.19	222.47
price to sales ratio	4.01	3.41	17.31
pocfratio	110.61	71.0	55.78
pfcf ratio	-189.66	308.31	-161.52
pb ratio	13.47	10.69	25.99
ptb ratio	13.47	10.69	25.99
ev to sales	5.56	4.69	18.38
enterprise value over ebitda	59.44	60.41	-1.59
ev to operating cash flow	153.47	97.63	57.20
ev to free cash flow	-263.15	423.92	-162.07
earnings yield	0.0	-0.0	181.65
free cash flow yield	-0.01	0.0	-262.56
debt to equity	5.16	4.36	18.26
debt to assets	0.44	0.43	3.97
net debt to ebitda	16.6	16.47	0.77
current ratio	1.32	1.35	-2.01
interest coverage	1.53	3.04	-49.59
income quality	10.11	-12.86	178.61
dividend yield	0.0	0.0	-8.95
payout ratio	2.32	-2.08	211.51
sales general and administrative to revenue	0.05	0.05	-3.37
research and ddevelopement to revenue	0.05	0.06	-19.26
intangibles to total assets	0.1	0.1	3.77
capex to operating cash flow	1.58	0.77	105.69
capex to revenue	0.06	0.04	54.90
capex to depreciation	0.99	0.73	36.09
stock based compensation to revenue	0	0	NaN
graham number	3.87	4.45	-13.05
roic	0.01	-0.04	122.30
return on tangible assets	0.0	-0.0	190.82
graham net net	-55.05	-52.47	-4.91
working capital	742600000	860600000	-13.71
tangible asset value	-109000000	-11200000	-873.21
net current asset value	-2747800000	-2635500000	-4.26
invested capital	3612300000	3697100000	-2.29
average receivables	533900000	642850000	-16.95
average payables	1251600000	1152350000	8.61
average inventory	2204750000	2175300000	1.35
days sales outstanding	24.39	25.19	-3.16
days payables outstanding	75.25	74.12	1.53
days of inventory on hand	136.01	127.31	6.83
receivables turnover	3.69	3.57	3.26
payables turnover	1.2	1.21	-1.51
inventory turnover	0.66	0.71	-6.39
roe	0.01	-0.01	202.87
capex per share	1.43	1.0	42.60

• Negative

  ROE: Return on Equity (ROE) increased to 0.01 on 2024-07-31 Q2 from -0.01 on 2024-04-30 Q1, representing a change of 202.87%. However, ROE is <= 5%, suggesting that the company has not been generating high returns for its shareholders.

  Debt-to-Equity Ratio: Debt-to-Equity Ratio increased to 5.16 on 2024-07-31 Q2 from 4.36 on 2024-04-30 Q1, representing a change of 18.26%. The debt-to-equity ratio has been increasing, indicating that the company has been relying more on debt financing. A ratio of 2.0 or higher is usually considered risky.

• Positive

  PE Ratio: Price-to-Earnings (P/E) Ratio increased to 279.46 on 2024-07-31 Q2 from -228.19 on 2024-04-30 Q1, representing a change of 222.47%. Indicating an increase in the relative valuation of the company's stock.

• Neutral

  Current Ratio: Current Ratio decreased to 1.32 on 2024-07-31 Q2 from 1.35 on 2024-04-30 Q1, representing a change of -2.01%. The current ratio has been declining, suggesting a decrease in the company's short-term liquidity. However, it is still above 1, indicating the ability to cover short-term obligations.

Growth Rates ⓘ

• Annual Growth

• Quarterly Growth

Intrinsic Value (Discounted Cash Flow) ⓘ

Positive Sentiment: Discounted Cash Flow value is 79.74 which is higher than current price 67.75, indicates the company may be undervalued.